2013
DOI: 10.1021/pr4004294
|View full text |Cite
|
Sign up to set email alerts
|

Differential Proteomic Analysis of Cancer Stem Cell Properties in Hepatocellular Carcinomas by Isobaric Tag Labeling and Mass Spectrometry

Abstract: Malignant tumors are relatively resistant to treatment due to their heterogeneous nature, drug resistance, and tendency for metastasis. Recent studies suggest that a subpopulation of cancer cells is responsible for the malignant outcomes. These cells are considered as cancer stem cells (CSC). Although a number of molecules have been identified in different cancer cells as markers for cancer stem cells, no promising markers are currently available for hepatocellular carcinoma cells. In this study, two clones of… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
7
0

Year Published

2014
2014
2022
2022

Publication Types

Select...
6
2

Relationship

1
7

Authors

Journals

citations
Cited by 13 publications
(7 citation statements)
references
References 32 publications
0
7
0
Order By: Relevance
“…For instance, Huang et al have reported the iTRAQ-based quantitative analysis of the recurrence/metastasis of Huge HCC (diameter is larger than 10 cm) at different stages, and identified two biomarkers for distinguishing and predicting the early recurrence/metastasis behaviors of Huge HCC [26]; Wang et al have reported the serum proteome of metastatic HCC using the iTRAQ-based quantitative analysis and identified a metastasis-associated biomarker [27]. Ko et al have reported the iTRAQ-based quantitative analysis of HCC cancer stem cell proteome [28]. Meanwhile, the iTRAQ-based quantitative study of the proteome changes and the secreted proteome changes during HBV infection have also been reported [29,30].…”
Section: Introductionmentioning
confidence: 99%
“…For instance, Huang et al have reported the iTRAQ-based quantitative analysis of the recurrence/metastasis of Huge HCC (diameter is larger than 10 cm) at different stages, and identified two biomarkers for distinguishing and predicting the early recurrence/metastasis behaviors of Huge HCC [26]; Wang et al have reported the serum proteome of metastatic HCC using the iTRAQ-based quantitative analysis and identified a metastasis-associated biomarker [27]. Ko et al have reported the iTRAQ-based quantitative analysis of HCC cancer stem cell proteome [28]. Meanwhile, the iTRAQ-based quantitative study of the proteome changes and the secreted proteome changes during HBV infection have also been reported [29,30].…”
Section: Introductionmentioning
confidence: 99%
“…So far, several groups have reported the applying of iTRAQ based quantitative proteomics approach in the study of hepatic cancer, especially for the screening of diagnostic or prognostic protein biomarkers. He et al have reported the serum biomarker screening of AFP negative HBV related HCC through the iTRAQ based approach [35]; Ko et al have reported the iTRAQ based quantitative analysis of HCC cancer stem cell proteome [36]; Huang et al have reported the iTRAQ based serum biomarker screening of the HCC micro-vascular invasion [37]; Qin et al, Yu et al and Wang et al have reported the screening of metastatic related proteins of HCC through iTRAQ based approach [33,38,39]; the iTRAQ based quantitative study of proteome change during HBV infection has also been reported [40,41]. However, the application of iTRAQ labeling in studying the molecular mechanisms and screening for biomarkers associated with the early recurrence/metastasis of H-HCC has not yet been reported to our knowledge.…”
Section: Introductionmentioning
confidence: 99%
“…The samples were loaded on 24 OFFGEL wells. The separation was carried out for 48 h using the 3100 OFFGEL fractionator (Agilent Technologies, Wilmington, DE, USA) with a limiting current of 50 ÎŒA and a limit of 50 kV· h before holding the voltage at 500 V. The samples from 24 fractions were cleaned‐up using C18 Spin columns for further analysis .…”
Section: Methodsmentioning
confidence: 99%